A detailed history of Boxer Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Boxer Capital, LLC holds 690,000 shares of PRTA stock, worth $14.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
690,000
Previous 665,000 3.76%
Holding current value
$14.1 Million
Previous $24.2 Million 29.28%
% of portfolio
0.89%
Previous 1.24%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$24.75 - $40.66 $618,750 - $1.02 Million
25,000 Added 3.76%
690,000 $17.1 Million
Q4 2023

Feb 14, 2024

BUY
$32.31 - $52.32 $11.8 Million - $19.1 Million
365,000 Added 121.67%
665,000 $24.2 Million
Q3 2021

Nov 15, 2021

BUY
$48.2 - $78.89 $14.5 Million - $23.7 Million
300,000 New
300,000 $21.4 Million
Q4 2019

Feb 14, 2020

SELL
$7.48 - $17.01 $595,393 - $1.35 Million
-79,598 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$6.89 - $10.45 $548,430 - $831,799
79,598 New
79,598 $624,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $957M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.